Hearing Aids Now Available Over-the-Counter
Consumers will now be able to buy hearing aids directly off store shelves and at dramatically lower prices as federal ...
Marijuana-Opioid Switcheroo
The pardoning of federal marijuana convictions may appear to be a step toward the decriminalization of drugs, but there will ...
Importance of Self-doubt
Most providers feign confidence when they should acknowledge their uncertainty. It would improve their clinical decisions.
Serial Surveys of Perceptions
We unveiled the first of many surveys that capture patient perceptions. We expand on their purpose and disclose future questions.
Records Reveal Massive Overcharges to Government
Health officials will make public audits of Medicare Advantage health plans that reveal hundreds of millions of dollars in overcharges.
Male Birth Control Options?
In the wake of the reversal of Roe v. Wade, developing more contraception options for everyone becomes even more important.
Climate Change Magnifies Health Impacts of Wildfire Smoke
People increasingly face risks such as climate change making wildfires, drought, dust storms, and floods more frequent.
Fentanyl Candy Colored Rainbows
The latest scare tactic in the war on drugs appears to be more of a farce than anything based on ...
The Problem of Celebrity Patients
When celebrities share their medical diagnosis, they become narratives through which the public understands the disease.
The Trouble With PRN
Giving patients the autonomy to take medications as needed becomes a liability for chronic pain patients taking opioids.
Medical Debt Sunk Her Credit
Medical debt has sunk her credit score so low that she has struggled to qualify for loans, and applying for ...
Abortion Bans Skirt a Medical Reality
The U.S. has one of the highest teen birth rates among developed nations, even after three decades of improvement.
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read more